Form 4: ANI Pharmaceuticals SVP, Chief HR Officer Krista Davis Reports Stock Transaction
SEC Form 4 Filing
Krista Davis, SVP, Chief HR Officer of ANI Pharmaceuticals, reports the disposition of 1,486 shares of common stock to cover tax obligations related to vesting restricted stock.
Summary
- On September 12, 2024, Krista Davis, SVP, Chief HR Officer of ANI Pharmaceuticals, disposed of 1,486 shares of common stock.
- The shares were withheld for tax purposes in connection with the vesting of 4,108 shares of restricted stock.
- The transaction was exempt under Rule 16(b)-3.
- Following the transaction, Davis beneficially owns 50,059 shares of ANI Pharmaceuticals common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to stock transactions, and it doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine disposal of shares for tax purposes.
Key Dates
| Date | Description |
|---|---|
| 09/12/2024 | Date of stock transaction (disposal of shares) |
| 09/13/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.